Abstract:Introduction: Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) are critical components of the extracellular matrix (ECM) in colorectal cancer (CRC). We aimed to evaluate the prognostic value of MMP-2 and MMP-9 in patients with CRC. Methods: We performed a meta-analysis of cohort studies with available data on the effect of MMP-2 and MMP-9 expression on both disease-free survival (DFS) and overall survival (OS) by the risk ratios (RRs) with their 95% confidence intervals (CIs). Studies were subgrouped based on the different tissue types, including cancer tissue and normal tissue, and the subgroup effect of MMP expression in different tissues was analyzed through meta-regression. To ensure the quality and reduce the risk of bias, the Newcastle‒Ottawa Scale (NOS) was used to assess the included studies. A sensitivity analysis was randomly performed to assess the potential impact of each study on our results. Results: Eighteen trials were selected (Table 1) and included a total of 3944 patients. According to our primary meta-analysis, the expression of MMP-2 was significantly associated with a decrease in OS (RR = 1.75, 95% CI = 1.34 to 2.29, P < 0.001) and DFS (RR = 2.62, 95% CI = 1.25 to 5.49, P < 0.001), and the expression of MMP-9 was not significantly associated with a decrease in OS (RR = 1.48, 95% CI = 0.97 to 2.24, P = 0.069) or DFS (RR = 1.60, 95% CI = 0.87 to 2.94, P = 0.133). According to the subgroup analysis of MMPs in different tissues, high MMP-2 expression in cancer tissue (RR = 1.90, 95% CI = 1.29 to 2.79) and normal tissue (RR = 1.59, 95% CI = 1.17 to 2.17) were significant indicators of poor OS. High MMP-2 expression in cancer tissue was significant indicator of poor DFS (RR = 2.12, 95% CI = 1.09 to 4.11). MMP-9 expression was also associated with poor OS (RR = 1.40, 95% CI = 0.85 to 2.29), but the difference in OS between the high and low expression groups was not statistically significant. Conclusions: High MMP-2 expression, especially in cancer tissue, is significantly associated with both poor DFS and poor OS in patients with CRC. High MMP-9 expression tended to indicate a poor prognosis of CRC but the correlation was not significant.

The Study of Expression of Matrix Metalloproteinases-2 in Patients with Colorectal Cancer

The expression of tumor metastasis suppressor gene KAI1 and matrix metalloproteinase 2 in breast cancer tissues

Expression of cyclooxygenase 2 in colorectal cancer

Relationship of MMP-2mRNA Expression with Clinical Pathological Features and Prognosis in Gastric Cancer

EXPRESSION OF MATRIX METALLOPROTEINASE 2 AND TISSUE INHIBITOR OF METALLOPROTEINASE 2 Mrnas IN COLORECTAL NEOPLASIA

Expression of Matrix Metalloproteinase-2 in Lymph Node-Negative Breast Carcinoma and Its Clinical Value

Clinical Research of MMP-2 and TIMP-2 Expression in Patients of Malignant Tumor

Expression and significance of MMP-2 and C-erbB-2 in human primary sporadic colorectal carcinoma and their metastases

Expression and Significance of MMP-2 and TIMP-2 in Human Colorectal Carcinoma and Its Metastasis

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

Expressions of Matrix Metalloproteinase 2 and Carbohydrate Antigen 50 in Colorectal Carcinoma,Transitional Mucosa and Normal Colorectal Mucosa and Its Clinical Significance

Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer

EXPRESSION OF MATRIX METALLOPROTEINASE-2 IN LUNG SQUAMOUS CELL CARCINOMA

Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis

Relationship between expression of MMP-2 and cervical lymph node micrometastasis in oral squamous cell carcinoma

Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis

Expressions of COX-2 and MMP-2 in Breast Cancer and Their Significances

Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer

Expression of Survivin and MMP-2 in breast carcinoma and their correlation

Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients

The Expression and Significance of MMP-2 in Human Pancreatic Carcinoma